These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 18455749)

  • 1. Intragenotypic JFH1 based recombinant hepatitis C virus produces high levels of infectious particles but causes increased cell death.
    Mateu G; Donis RO; Wakita T; Bukh J; Grakoui A
    Virology; 2008 Jul; 376(2):397-407. PubMed ID: 18455749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Robust hepatitis C genotype 3a cell culture releasing adapted intergenotypic 3a/2a (S52/JFH1) viruses.
    Gottwein JM; Scheel TK; Hoegh AM; Lademann JB; Eugen-Olsen J; Lisby G; Bukh J
    Gastroenterology; 2007 Nov; 133(5):1614-26. PubMed ID: 17983807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Robust full-length hepatitis C virus genotype 2a and 2b infectious cultures using mutations identified by a systematic approach applicable to patient strains.
    Li YP; Ramirez S; Gottwein JM; Scheel TK; Mikkelsen L; Purcell RH; Bukh J
    Proc Natl Acad Sci U S A; 2012 May; 109(18):E1101-10. PubMed ID: 22467829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptive mutation F772S-enhanced p7-NS4A cooperation facilitates the assembly and release of hepatitis C virus and is associated with lipid droplet enlargement.
    Duan X; Anwar MI; Xu Z; Ma L; Yuan G; Chen Y; Liu X; Xia J; Zhou Y; Li YP
    Emerg Microbes Infect; 2018 Aug; 7(1):143. PubMed ID: 30087320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell culture-adaptive mutations in hepatitis C virus promote viral production by enhancing viral replication and release.
    Wang Q; Li Y; Liu SA; Xie W; Cheng J
    World J Gastroenterol; 2018 Mar; 24(12):1299-1311. PubMed ID: 29599605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of a recombinant reporter hepatitis C virus useful for the analyses of virus entry, intra-cellular replication and virion production.
    Kamada K; Shoji I; Deng L; Aoki C; Ratnoglik SL; Wakita T; Hotta H
    Microbes Infect; 2012 Jan; 14(1):69-78. PubMed ID: 21917232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compensatory mutations in E1, p7, NS2, and NS3 enhance yields of cell culture-infectious intergenotypic chimeric hepatitis C virus.
    Yi M; Ma Y; Yates J; Lemon SM
    J Virol; 2007 Jan; 81(2):629-38. PubMed ID: 17079282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cooperation between the Hepatitis C Virus p7 and NS5B Proteins Enhances Virion Infectivity.
    Aligeti M; Roder A; Horner SM
    J Virol; 2015 Nov; 89(22):11523-33. PubMed ID: 26355084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and application of hepatitis C reporter viruses with genotype 1 to 7 core-nonstructural protein 2 (NS2) expressing fluorescent proteins or luciferase in modified JFH1 NS5A.
    Gottwein JM; Jensen TB; Mathiesen CK; Meuleman P; Serre SB; Lademann JB; Ghanem L; Scheel TK; Leroux-Roels G; Bukh J
    J Virol; 2011 Sep; 85(17):8913-28. PubMed ID: 21697486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C Virus Escape Studies of Human Antibody AR3A Reveal a High Barrier to Resistance and Novel Insights on Viral Antibody Evasion Mechanisms.
    Velázquez-Moctezuma R; Galli A; Law M; Bukh J; Prentoe J
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30487284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incorporation of primary patient-derived glycoproteins into authentic infectious hepatitis C virus particles.
    Doerrbecker J; Friesland M; Riebesehl N; Ginkel C; Behrendt P; Brown RJ; Ciesek S; Wedemeyer H; Sarrazin C; Kaderali L; Pietschmann T; Steinmann E
    Hepatology; 2014 Aug; 60(2):508-20. PubMed ID: 24771613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amino Acid Mutations in the NS4A Region of Hepatitis C Virus Contribute to Viral Replication and Infectious Virus Production.
    Murayama A; Sugiyama N; Suzuki R; Moriyama M; Nakamura N; Mochizuki H; Wakita T; Kato T
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of JFH1-based cell culture systems for hepatitis C virus genotype 4a and evidence for cross-genotype neutralization.
    Scheel TK; Gottwein JM; Jensen TB; Prentoe JC; Hoegh AM; Alter HJ; Eugen-Olsen J; Bukh J
    Proc Natl Acad Sci U S A; 2008 Jan; 105(3):997-1002. PubMed ID: 18195353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient production of infectious hepatitis C virus with adaptive mutations in cultured hepatoma cells.
    Bungyoku Y; Shoji I; Makine T; Adachi T; Hayashida K; Nagano-Fujii M; Ide YH; Deng L; Hotta H
    J Gen Virol; 2009 Jul; 90(Pt 7):1681-1691. PubMed ID: 19282429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adaptive Mutations Enhance Assembly and Cell-to-Cell Transmission of a High-Titer Hepatitis C Virus Genotype 5a Core-NS2 JFH1-Based Recombinant.
    Mathiesen CK; Prentoe J; Meredith LW; Jensen TB; Krarup H; McKeating JA; Gottwein JM; Bukh J
    J Virol; 2015 Aug; 89(15):7758-75. PubMed ID: 25995244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of infectious chimeric hepatitis C virus genotype 2b harboring minimal regions of JFH-1.
    Murayama A; Kato T; Akazawa D; Sugiyama N; Date T; Masaki T; Nakamoto S; Tanaka Y; Mizokami M; Yokosuka O; Nomoto A; Wakita T
    J Virol; 2012 Feb; 86(4):2143-52. PubMed ID: 22156532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The NS3 helicase and NS5B-to-3'X regions are important for efficient hepatitis C virus strain JFH-1 replication in Huh7 cells.
    Murayama A; Date T; Morikawa K; Akazawa D; Miyamoto M; Kaga M; Ishii K; Suzuki T; Kato T; Mizokami M; Wakita T
    J Virol; 2007 Aug; 81(15):8030-40. PubMed ID: 17522229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cell culture adapted HCV JFH1 variant that increases viral titers and permits the production of high titer infectious chimeric reporter viruses.
    Liu S; Xiao L; Nelson C; Hagedorn CH
    PLoS One; 2012; 7(9):e44965. PubMed ID: 23028707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracytoplasmic stable expression of IgG1 antibody targeting NS3 helicase inhibits replication of highly efficient hepatitis C Virus 2a clone.
    Chandra PK; Hazari S; Poat B; Gunduz F; Prabhu R; Liu G; Burioni R; Clementi M; Garry RF; Dash S
    Virol J; 2010 Jun; 7():118. PubMed ID: 20529250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras.
    Pietschmann T; Kaul A; Koutsoudakis G; Shavinskaya A; Kallis S; Steinmann E; Abid K; Negro F; Dreux M; Cosset FL; Bartenschlager R
    Proc Natl Acad Sci U S A; 2006 May; 103(19):7408-13. PubMed ID: 16651538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.